Cargando…
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
The phenylalanine–tyrosine–dopa–dopamine pathway provides dopamine to the brain. In this process, tyrosine hydroxylase (TH) is the rate-limiting enzyme that hydroxylates tyrosine and generates levodopa (l-dopa) with tetrahydrobiopterin (BH(4)) as a coenzyme. Here, we show that oral berberine (BBR) m...
Autores principales: | Wang, Yan, Tong, Qian, Ma, Shu-Rong, Zhao, Zhen-Xiong, Pan, Li-Bin, Cong, Lin, Han, Pei, Peng, Ran, Yu, Hang, Lin, Yuan, Gao, Tian-Le, Shou, Jia-Wen, Li, Xiao-Yang, Zhang, Xian-Feng, Zhang, Zheng-Wei, Fu, Jie, Wen, Bao-Ying, Yu, Jin-Bo, Cao, Xuetao, Jiang, Jian-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902645/ https://www.ncbi.nlm.nih.gov/pubmed/33623004 http://dx.doi.org/10.1038/s41392-020-00456-5 |
Ejemplares similares
-
Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017) -
Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2021) -
Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015) -
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
por: Pan, Libin, et al.
Publicado: (2023) -
Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)